Virginia Bosó - Search Results

Year	Number of Results
2008	2
2012	1
2013	2
2014	2
2015	2
2016	3
2017	5
2024	0

1

Pharmacogenomics and the treatment of acute myeloid leukemia.

Megías-Vericat JE, Montesinos P, Herrero MJ, Bosó V, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenomics. 2016 Jul;17(11):1245-1272. doi: 10.2217/pgs-2016-0055. Epub 2016 Jul 6. Pharmacogenomics. 2016. PMID: 27381050 Review.

2

Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.

Rojas LE, Herrero MJ, Bosó V, García-Eliz M, Poveda JL, Librero J, Aliño SF. Rojas LE, et al. Among authors: boso v. Pharmacogenet Genomics. 2013 Oct;23(10):509-17. doi: 10.1097/FPC.0b013e3283642fb3. Pharmacogenet Genomics. 2013. PMID: 23873120 Review.

3

Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome.

Perez-Aytes A, Marin-Reina P, Boso V, Ledo A, Carey JC, Vento M. Perez-Aytes A, et al. Among authors: boso v. Eur J Med Genet. 2017 Jan;60(1):16-21. doi: 10.1016/j.ejmg.2016.09.014. Epub 2016 Sep 14. Eur J Med Genet. 2017. PMID: 27639443

4

SNPs and taxane toxicity in breast cancer patients.

Bosó V, Herrero MJ, Santaballa A, Palomar L, Megias JE, de la Cueva H, Rojas L, Marqués MR, Poveda JL, Montalar J, Aliño SF. Bosó V, et al. Pharmacogenomics. 2014;15(15):1845-58. doi: 10.2217/pgs.14.127. Pharmacogenomics. 2014. PMID: 25495407

5

Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.

Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Martínez-Cuadrón D, Rojas L, Rodríguez-Veiga R, Boluda B, Sendra L, Cervera J, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Leuk Lymphoma. 2017 Dec;58(12):2880-2894. doi: 10.1080/10428194.2017.1323267. Epub 2017 Jun 2. Leuk Lymphoma. 2017. PMID: 28573946

6

Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation.

Sánchez-Lázaro I, Herrero MJ, Jordán-De Luna C, Bosó V, Almenar L, Rojas L, Martínez-Dolz L, Megías-Vericat JE, Sendra L, Miguel A, Poveda JL, Aliño SF. Sánchez-Lázaro I, et al. Among authors: boso v. Pharmacogenomics. 2015;16(9):971-9. doi: 10.2217/pgs.15.39. Epub 2015 Jun 24. Pharmacogenomics. 2015. PMID: 26107754

7

Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation.

Ruiz J, Herrero MJ, Bosó V, Megías JE, Hervás D, Poveda JL, Escrivá J, Pastor A, Solé A, Aliño SF. Ruiz J, et al. Among authors: boso v. Int J Mol Sci. 2015 Aug 25;16(9):20168-82. doi: 10.3390/ijms160920168. Int J Mol Sci. 2015. PMID: 26307985 Free PMC article.

8

Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Rojas L, Martínez-Cuadrón D, Hervás D, Boluda B, García-Robles A, Rodríguez-Veiga R, Martín-Cerezuela M, Cervera J, Sendra L, Sanz J, Miguel A, Lorenzo I, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Leuk Lymphoma. 2017 May;58(5):1197-1206. doi: 10.1080/10428194.2016.1231405. Epub 2016 Oct 4. Leuk Lymphoma. 2017. PMID: 27701910

9

Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice.

Aguas Peris M, Bosó V, Navarro B, Marqués-Miñana MR, Bastida G, Beltrán B, Iborra M, Sáez-González E, Monte-Boquet E, Poveda-Andrés JL, Nos P. Aguas Peris M, et al. Among authors: boso v. Inflamm Bowel Dis. 2017 Aug;23(8):1454-1460. doi: 10.1097/MIB.0000000000001182. Inflamm Bowel Dis. 2017. PMID: 28708805

10

Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia.

Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenet Genomics. 2017 Jul;27(7):270-274. doi: 10.1097/FPC.0000000000000286. Pharmacogenet Genomics. 2017. PMID: 28570300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year